DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹6,840 Cr | ₹5,785 Cr | ₹5,113 Cr | ₹5,009 Cr | ₹4,596 Cr |
What is the latest Total Non-Current Assets ratio of DIVIS LABORATORIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹6,840 Cr |
| Mar2024 | ₹5,785 Cr |
| Mar2023 | ₹5,113 Cr |
| Mar2022 | ₹5,009 Cr |
| Mar2021 | ₹4,596 Cr |
How is Total Non-Current Assets of DIVIS LABORATORIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,840 Cr | 18.24 | |
| Mar2024 | ₹5,785 Cr | 13.14 | |
| Mar2023 | ₹5,113 Cr | 2.08 | |
| Mar2022 | ₹5,009 Cr | 8.97 | |
| Mar2021 | ₹4,596 Cr | - | |
Compare Total Non-Current Assets of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹161,211.6 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
| MANKIND PHARMA | ₹85,841.5 Cr | 1.9% | -7.1% | -15.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 3.8% |
-4.7% |
11.5% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses